Dr. Luc BoudreauMolecular Immunologist
During his doctoral formation, Dr Luc Boudreau developed an expertise in the regulation of inflammatory mediators such as leukotrienes. This potent inflammatory family of mediators actively participates in the development and progression of numerous chronic inflammatory diseases. In 2012, he pursued a postdoctoral formation at the Centre Hospitalier de l’Université Laval (CHUL) where he studied the roles of cell-derived microparticles/microvesicles in inflammatory diseases. Amongst some of his most notable discoveries during his postdoctoral fellowship was the identification of a novel cell-derived microvesicle family that retained a functional mitochondrion, termed mitochondria-containing microparticles. Interestingly, these cell-derived microvesicles cargo bioactive compounds, including inflammatory mediators, thus actively participating in the inflammatory response.
Since July 2015, Dr Boudreau is an assistant professor in the Department of Chemistry and Biochemistry at the Université de Moncton, where he has established his independent research program which is based on evaluating the correlation between cell-derived activation and diseases. He has a particular interest in cell-derived containing mitochondria that do not exhibit phosphatidylserine at their surface and that can modulate the phenotype of immune cells by mitochondrial horizontal transfer.
Dr. Boudreau has obtained funding from several agencies since 2015, including the Canadian Institutes of Health Research (CIHR), the New Brunswick Health Research Foundation (NBHRF), the Natural Sciences and Engineering Research Council of Canada (NSERC), the New Brunswick Innovation Foundation (NBIF) and the Leukemia and Lymphoma Society of Canada.